Author

E. Midtbust

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. Kiviaho· 2 shared A. Sharma· 2 shared A. Urbanucci· 2 shared M. B. Rye· 2 shared M. K. Andersen· 2 shared M. Nykter· 2 shared M. Wess· 2 shared M.-B. Tessem· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Kiviaho

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Deep phenotyping of the prostate tumor microenvironment reveals molecular stratifiers of relapse and links inflammatory chemokine expression to aberrant metabolism

S. Krossa, M. K. Andersen, E. Midtbust, M. Wess, A. Kiviaho, A. Sharma, T. Viset, O. Storkersen, G. F. Giskeodegard, M. Nykter, A. Urbanucci, M. B. Rye, M.-B. Tessem

The paper identifies molecular signatures in prostate cancer that link inflammatory chemokine expression to metabolic changes and relapse risk.

bioRxiv · May 13, 2024 · PreprintCancer Biology

Immunosuppression in the prostate tumor microenvironment is tied to androgen deprivation therapy-resistant club-like cells

A. Kiviaho, S. K. Eerola, H. M. L. Kallio, M. K. Andersen, X. Spotbeen, A. Giesen, C. T. A. Parker, S. Taavitsainen, O. Hantula, M. Marttinen, I. Hermelo, M. Ismail, E. Midtbust, M. Wess, W. Devlies, , M. Nykter

The paper identifies club-like cells in the prostate tumor microenvironment that contribute to androgen deprivation therapy resistance through immune suppression.

bioRxiv · Mar 25, 2024 · PreprintCancer Biology